Gene: RANBP3
Official Full Name: RAN binding protein 3provided by HGNC
Gene Summary: This gene encodes a protein with a RanBD1 domain that is found in both the nucleus and cytoplasm. This protein plays a role in nuclear export as part of a heteromeric complex. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO34095 | RANBP3 Knockout cell line (HeLa) | Human | RANBP3 | 1:3~1:6 | Negative | Online Inquiry |
KO34096 | RANBP3 Knockout cell line (HCT 116) | Human | RANBP3 | 1:2~1:4 | Negative | Online Inquiry |
KO34097 | RANBP3 Knockout cell line (HEK293) | Human | RANBP3 | 1:3~1:6 | Negative | Online Inquiry |
KO34098 | RANBP3 Knockout cell line (A549) | Human | RANBP3 | 1:3~1:4 | Negative | Online Inquiry |
RANBP3 Gene Knockout Cell Lines are engineered cellular models in which the RANBP3 gene has been selectively disrupted. RANBP3 (Ran-binding protein 3) is crucial for various cellular processes, including nuclear transport and regulation of RNA/protein interactions. By providing knockout versions of these cell lines, researchers can investigate the specific roles and mechanisms of the RANBP3 protein within cellular pathways, elucidating its involvement in processes such as cell cycle regulation, gene expression, and tumorigenesis.
The operational mechanism behind RANBP3 Gene Knockout Cell Lines allows for the study of downstream effects when RANBP3 expression is abolished. This includes analyzing changes in cellular localization of RNA-binding proteins, alterations in nuclear-cytoplasmic transport mechanisms, and shifts in cellular signaling pathways, which are pivotal for understanding disease states, especially cancers where RANBP3 may play an oncogenic role.
In terms of scientific significance, these knockout cell lines serve as invaluable tools in both fundamental and applied research settings. They facilitate the exploration of gene function, serve as platforms for drug discovery, and assist in developing targeted therapies that address the specific dysregulation of RANBP3 in various diseases. Furthermore, they provide a robust model for validating the effects of pharmacological agents that modulate the activity of the RANBP3 protein.
The advantages of using RANBP3 Gene Knockout Cell Lines over other alternatives lie in their specificity and reliability. Unlike transient knockdown approaches which may lead to incomplete gene suppression, these stable knockout lines ensure consistent expression levels and phenotypic stability, ultimately yielding more reproducible results. Additionally, these cell lines can be tailored for different experimental needs, allowing researchers to customize their study environment.
In conclusion, RANBP3 Gene Knockout Cell Lines are an essential resource for researchers and clinicians seeking to better understand the multifaceted roles of RANBP3 in health and disease. Our company specializes in providing high-quality biological products, and we are committed to supporting the scientific community with tools that advance research and foster innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.